The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Cryoport Inc. (CYRX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -0.16%, to $19.15. The Cryoport Inc. has recorded 4,638 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The company is listed on the NASDAQ and operates within the Integrated Freight & Logistics industry segment. At the end of the last regular session, the stock closed at $19.18 and fluctuated between $21.57 as its day high and $17.96 as its day low. The current market capitalization of Cryoport Inc. is $1.04B. A total of 0.78 million shares were traded on the day, compared to an average of 430.17K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CYRX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 3 SELLs from insiders. Insiders purchased 108,579 shares during that period but sold 11,958.
In the most recent transaction, BERMAN RICHARD J sold 7,250 shares of CYRX for 19.63 per share on Dec 01. After the transaction, the Director now owns 0 company shares. In a previous transaction on Aug 16, BERMAN RICHARD J sold 2,708 shares at 43.05 per share. CYRX shares that Director owns now total 107,203.
Among the insiders who sold shares, Hariri Robert J disposed of 2,000 shares on Aug 11 at a per-share price of $43.29. This resulted in the Director holding 7,911 shares of CYRX after the transaction.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CYRX in the last 3 months, the mean price target is $31.00 with high estimates of $40.00 and low estimates of $24.00. In terms of 52-week highs and lows, CYRX has a high of $45.36 and a low of $15.63.
As of this writing, CYRX has an earnings estimate of -$0.19 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.26. The company reported an EPS of -$0.23 in the last quarter, which was -53.30% lower than expectations of -$0.15.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 9 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CYRX is Overweight with a score of 4.86. A total of 9 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.